Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.

ChampionX (CHX) closed the last trading session at $30.37, gaining 5.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

ChampionX CHX shares ended the last trading session 12.6% higher at $25.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

THE WOODLANDS, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX), a global leader in oilfield technology, announced today its ...

Looking at the universe of stocks we cover at Dividend Channel, on 4/4/25, ChampionX Corp (Symbol: CHX) will trade ex-dividend, for its quarterly dividend of $0.095, payable on 4/25/25.